Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now shown on the page, replacing the previous v3.4.2 label.
    Difference
    0.0%
    Check dated 2026-03-11T14:57:47.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The government funding notice and Revision: v3.4.1 were removed.
    Difference
    0.2%
    Check dated 2026-02-11T09:53:42.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding status notice was added and a new 2025 publication citation (KEEPSAKE 2) was added to Publications, while the older online-ahead-of-print citation was removed and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T06:30:47.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds a glossary display option and metadata fields such as Last Update Submitted that Met QC Criteria and Last Update Posted, and updates the No FEAR Act Data label and the revision to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-28T04:32:50.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:40:17.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The Locations section was expanded with numerous new sites across the United States, Argentina, Australia, and various countries in Europe and beyond. Many regional locations were added to reflect broader geographic coverage.
    Difference
    3%
    Check dated 2025-12-23T09:24:41.000Z thumbnail image

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.